CTLA4 and colorectal carcinoma: CTLA-4 was an inhibitory immune checkpoint that was overexpressed in the CRC tissues and the CRC cell line SW480, and capecitabine treatment resulted in a significant downregulation of CTLA-4 expression in SW480 cells [40].